Big cannabis stocks are rallying on Monday, with many posting double-digits gains.
So what’s going on?
Alan Brochstein, author of the 420 Investor and founder of New Cannabis Ventures, said the move "seems driven by Canadian LPs, and some of that may be short-covering."
If what we're seeing is short covering, he said the move is broad and spans across the market, as volumes are showing considerable upticks.
"I would note that small-caps in the U.S. are breaking to recent highs, and perhaps there is in general a stronger appetite for risk by investors," Brochstein told Benzinga.
Among the top gainers at time of writing:
- Greenlane Holdings Inc GNLN up 23%
- Acreage Holdings Inc ACRGF up 19%
- Medmen Enterprises Inc MMNFF up 12.8%
- Tilray Inc TLRY up 12.4%
- Canopy Growth CGC up 10%
- Hexo Corp HEXO up 10.9%
- Aphria Inc APHA up 8.2%
- Cronos Group Inc CRON up 6.7%
- Curaleaf Holdings Inc CURLF up 6.7%
- Aurora Cannabis Inc ACB up 6%
Matt Markiewicz, Managing Director of Innovation Shares, currently in charge of the firm’s cannabis ETF, seems to agree with Brochstein: short-covering looks like the main driver behind the rally right now.
“With no fundamental news driving the space today, it smells like a classic short-cover rally especially in the blue chip LPs,” he told Benzinga.
To illustrate his point, Markiewicz brought up one of the most popular cannabis shorts: Tilray. The stock has 22% of its float short right now; this is pretty high compared to other Canadian LPs such as Canopy, at 18%, and Organigram at 8%.
“With nearly 17 million shares short right now, Tilray’s short interest is up over 50% in a month. These types of sharp moves, like we've seen in the first half hour today, have really forced short sellers’ hands early in the trading session,” he explained.
“On the whole though, there is a general bid for risk and small cap equities in the market today and cannabis leveraged names are along for the ride.”
This price action is also giving a boost to cannabis ETFs:
- The ETFMG Alternative Harvest ETF MJ up 4.75%.
- The AdvisorShares Pure Cannabis ETF YOLO up 4.74%.
- The Cannabis ETF THCX up 5.38%.
- The Amplify Seymour Cannabis ETF CNBS up 5.44%.
'No Good Reason'
Unlike his peers above, Dan Ahrens, a Managing Director and the Chief Operating Officer of AdvisorShares, thinks "there's no good reason a stock like Tilray or HEXO or Cronos should be up like this."
On the other hand, he noted a stock like Trulieve TCNNF "should be way up with Florida setting record sales. But not Tilray or HEXO.
"I think it's at least miss-placed optimism. Maybe even an actual short squeeze. People reading about dispensaries being essential, and big sales increases, then buying up just the known, heavily-traded cannabis names like Tilray," he concluded.
Lead image by Ilona Szentivanyi. Copyright: Benzinga.
Versión en Español en El Planteo: Por qué Están Subiendo las Acciones de Cannabis Hoy: Tilray, Canopy Growth, Aurora, Curaleaf y Más
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Missed the first wave of cannabis investments? Don’t make that mistake again.
Experts believe cannabis stocks have found their floor and are now poised for unprecedented growth.
Join Benzinga PotProfits. Our in-house canna stock expert, Michael Berger, is on a mission to uncover the most promising cannabis stocks poised for growth, even in a dull market. He leaves no bud unturned to bring you the juiciest potential double-digit opportunities!
Just this year, the PotProfits portfolio has seen smoking-hot gains like:
- 47.10% with $GTBIF
- 40.23% with $TCNNF
- 21.50% with $VFF